BlinkLab company, a leader in AI-powered digital diagnostics for neurodevelopmental conditions, has announced it has been selected as technology partner for a landmark national autism screening and capacity-building initiative in Morocco.
This initiative is the first and most comprehensive of its kind worldwide, positioning Morocco as a leading example for the international community, says a press release issued by the Australian Company.
BlinkLab has develop a cutting-edge Dx1 technology, an AI-powered, smartphone-based diagnostic aid designed to detect early signs of neurodevelopmental conditions, primarily autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in children as young as 18 to 24 months.
The technology acts as a “digital biomarker assessment” that uses a smartphone’s camera and AI to monitor facial reflex responses to stimuli while a child watches a video. This flagship technology will be integrated into Morocco’s nationwide early screening campaign for autism.
Scientific studies have demonstrated the effectiveness of BlinkLab’s non-invasive digital approach in enabling rapid, standardised, and objective detection of autism-related neurometric features.
The program is implemented in line with internationally recognised standards and approaches, including those acknowledged by World Health Organization (WHO).
The autism screening initiative includes the establishment of a Center of Excellence for Autism Research, Education and Training. Dr Henk-Jan Boele (BlinkLab Managing Director & CEO) and Prof Abdeslem El Idrissi (BlinkLab Scientific Board) will join a consortium of experts for the Center.
